• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿液中草酸钙结晶的抑制作用。

Inhibition of calcium oxalate crystallization in urine.

作者信息

Tiselius H G, Fornander A M, Nilsson M A

出版信息

Urol Res. 1987;15(2):83-6. doi: 10.1007/BF00260938.

DOI:10.1007/BF00260938
PMID:3590434
Abstract

Chromatographic separation of urine showed inhibition of calcium oxalate (CaOx)-crystallization among substances with both large and small molecular weights. Ultrafiltration showed that approximately 80 per cent of the inhibiting activity, as determined in 2 per cent urine, originated from substances with a molecular weight above 1,000. Dialysed urine was diluted to 7.5 mmol of creatinine per 1 and supersaturated with respect to CaOx. The rate of crystallization in these samples was slower in normal subjects than in stone formers (p less than 0.05). The inhibiting activity in diluted urine from the two groups did not differ and neither did the concentration of alcian blue precipitable polyanions. From measurements in diluted urine it was apparent that inhibition was demonstrable with a urine concentration as low as 0.3 per cent.

摘要

尿液的色谱分离显示,在大分子和小分子物质中均存在草酸钙(CaOx)结晶抑制现象。超滤结果表明,在2%的尿液中测定的约80%的抑制活性来自分子量高于1000的物质。将透析后的尿液稀释至每升含7.5 mmol肌酐,并使其相对于CaOx过饱和。这些样本中,正常受试者的结晶速率比结石形成者慢(p<0.05)。两组稀释尿液中的抑制活性没有差异,阿尔新蓝可沉淀聚阴离子的浓度也没有差异。从稀释尿液的测量结果来看,很明显,尿液浓度低至0.3%时仍可显示出抑制作用。

相似文献

1
Inhibition of calcium oxalate crystallization in urine.尿液中草酸钙结晶的抑制作用。
Urol Res. 1987;15(2):83-6. doi: 10.1007/BF00260938.
2
Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.正常人及特发性草酸钙结石患者中过饱和度与草酸钙结晶的关系。
Kidney Int. 1999 Mar;55(3):1041-50. doi: 10.1046/j.1523-1755.1999.0550031041.x.
3
Effects of urinary macromolecules on the crystallization of calcium oxalate.尿大分子对草酸钙结晶的影响。
Urol Res. 1990;18(6):381-5. doi: 10.1007/BF00297369.
4
Measurement of the risk of calcium oxalate crystallization in urine.尿液中草酸钙结晶风险的测量。
Urol Res. 1985;13(6):297-300. doi: 10.1007/BF00262660.
5
Inhibition of calcium oxalate crystallization by urinary macromolecules.尿大分子对草酸钙结晶的抑制作用。
Urol Res. 1991;19(3):165-9. doi: 10.1007/BF00303743.
6
Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.尿大分子对特发性结石形成者和健康对照者草酸钙成核的影响。
Clin Chim Acta. 1995 Jul 31;239(1):1-11. doi: 10.1016/0009-8981(95)06092-r.
7
Alpha-1-microglobulin: inhibitory effect on calcium oxalate crystallization in vitro and decreased urinary concentration in calcium oxalate stone formers.α1-微球蛋白:对草酸钙晶体形成的体外抑制作用及草酸钙结石患者尿浓度降低
Urol Res. 1999 Aug;27(4):243-9. doi: 10.1007/s002400050117.
8
Glycoprotein calcium oxalate crystal growth inhibitor in urine.尿液中的糖蛋白草酸钙晶体生长抑制剂。
Miner Electrolyte Metab. 1987;13(4):267-72.
9
The effect of pH on the risk of calcium oxalate crystallization in urine.pH对尿液中草酸钙结晶风险的影响。
Eur Urol. 1986;12(1):59-61. doi: 10.1159/000472578.
10
Polyanionic inhibitors of calcium oxalate crystal agglomeration in urine.尿液中草酸钙晶体团聚的聚阴离子抑制剂
Proc Eur Dial Transplant Assoc. 1983;20:440-4.

引用本文的文献

1
Is citrate an inhibitor of calcium oxalate crystal growth in high concentrations of urine?在高浓度尿液中,柠檬酸盐是草酸钙晶体生长的抑制剂吗?
Urol Res. 1996;24(2):67-71. doi: 10.1007/BF00431081.
2
Isolation and purification of a new glycoprotein from human urine inhibiting calcium oxalate crystallization.从人尿中分离纯化一种抑制草酸钙结晶的新型糖蛋白。
Urol Res. 1993 Jan;21(1):61-6. doi: 10.1007/BF00295195.
3
Effects of urinary macromolecules on the crystallization of calcium oxalate.尿大分子对草酸钙结晶的影响。

本文引用的文献

1
Evaluation of a routine method for determination of calcium oxalate crystal growth inhibition in diluted urine samples.评估一种用于测定稀释尿液样本中草酸钙晶体生长抑制的常规方法。
Clin Chem. 1981 Apr;27(4):565-8.
2
A proposal for a standard reference artificial urine in in vitro urolithiasis experiments.
Invest Urol. 1980 Sep;18(2):167-9.
3
Calcium oxalate crystalluria and inhibitors of crystallization in recurrent renal stone-formers.复发性肾结石患者的草酸钙结晶尿症及结晶抑制剂
Clin Sci. 1972 Oct;43(4):499-506. doi: 10.1042/cs0430499.
Urol Res. 1990;18(6):381-5. doi: 10.1007/BF00297369.
4
Inhibition of calcium oxalate crystallization by urinary macromolecules.尿大分子对草酸钙结晶的抑制作用。
Urol Res. 1991;19(3):165-9. doi: 10.1007/BF00303743.
4
The quantitative determination of glycosaminoglycans in urine with Alcian Blue 8GX.用阿尔辛蓝8GX对尿液中糖胺聚糖进行定量测定。
Biochem J. 1973 Feb;131(2):351-7. doi: 10.1042/bj1310351.
5
Inhibitory effects of urinary macromolecules on the crystallization of calcium oxalate.尿液大分子对草酸钙结晶的抑制作用。
Invest Urol. 1977 Sep;15(2):95-9.
6
Inhibitors and promoters of stone formation.结石形成的抑制剂和促进剂。
Kidney Int. 1978 May;13(5):361-71. doi: 10.1038/ki.1978.54.